The Wall Street analyst community has seen several notable analyst calls, including upgrades from JPMorgan to Oracle to overweight from neutral, and Evercore ISI reiterates Netflix as outperform. Barclays upgrades Arthur J. Gallagher to overweight, citing the insurance company's defensive play. Nomura upgrades Nio to buy from neutral and sees an "enhancing financial performance" for the EV company. Bank of America initiates Ligand Pharmaceuticals as buy, citing its unique business model. Barclays has upgraded Nike to overweight and anticipates the potential upside for the toy company. Barclays also reiterates Tesla's energy storage business is well positioned. However, Barclays warns that Nvidia is not pricing in enough capex growth for the company and that its future capex will likely be higher in 2028. Wolfe reiterates its price target on Eli Lilly shares and raises its rating to $1,325.